144 related articles for article (PubMed ID: 33624503)
1. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503
[TBL] [Abstract][Full Text] [Related]
2. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
[TBL] [Abstract][Full Text] [Related]
3. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
5. Tirapazamine combined with photodynamic therapy improves the efficacy of ABZSO nanoparticles on Echinococcosis granulosus via further enhancing "breaking-then-curing".
Gong Y; Zhou T; Aimaiti W; Lin Y; Xu Y; Yang J; Huang Z; Wen H; Jiang H; Wang J
J Photochem Photobiol B; 2023 Nov; 248():112798. PubMed ID: 37820499
[TBL] [Abstract][Full Text] [Related]
6. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
Yu J; Zhang X; Pei Z; Shuai Q
J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
[TBL] [Abstract][Full Text] [Related]
7. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
[TBL] [Abstract][Full Text] [Related]
8. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
10. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
Broekgaarden M; Weijer R; van Wijk AC; Cox RC; Egmond MR; Hoebe R; van Gulik TM; Heger M
J Biomed Nanotechnol; 2017 Feb; 13(2):204-20. PubMed ID: 29377650
[TBL] [Abstract][Full Text] [Related]
12. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
13. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
[TBL] [Abstract][Full Text] [Related]
14. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
15. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
[TBL] [Abstract][Full Text] [Related]
16. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer.
Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
[TBL] [Abstract][Full Text] [Related]
17. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
[TBL] [Abstract][Full Text] [Related]
18. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
Cheng D; Ji Y; Wang B; Jin T; Xu Y; Qian X; Zhu W
Int J Pharm; 2021 Jun; 603():120730. PubMed ID: 34029662
[TBL] [Abstract][Full Text] [Related]
19. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor.
Guo H; Wang L; Wu W; Guo M; Yang L; Zhang Z; Cao L; Pu F; Huang X; Shao Z
J Control Release; 2022 Nov; 351():151-163. PubMed ID: 36122895
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]